Vitamin A derivative suppresses immune response and cancer vaccine efficacy

[News]

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A-all-trans retinoic acid-compromises both the body's normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine.

More... (https://www.news-medical.net/news/20260105/Vitamin-A-derivative-suppresses-immune-response-and-cancer-vaccine-efficacy.aspx)